Position: Home > About Us > Profile

Beijing King Health Investment Co.,Ltd. is a new drug research and development company, founded in Beijing in 2002. Company is  focusing on R&D of Active Pharmaceutical Ingredients (API) and formulations as well as importation of finished dosage form, substance    from other countries.

KH Inv. is one of the subsidiary company of Grand Investment International Group. KH Inv. owns specialized teams of market research,   drug registration, importation, synthesis and quality control. Company has national wide drug distribution network operating by 3 GSP     certified drug marketing companies which are hold by the same Group.

In recent years, company began to develop a new business direction – Medical device; we've already built a sales system which covers  most provinces of China main land.

Currently, KH Inv. is cooperating with several foreign Pharmaceutical enterprises as their exclusive distributor in China, responsible for      drugs and medical devices registration, clinical trial, marketing and sales after launch.